retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Research Peptide Australia | GLP-1/GIP/Glucagon Eli Lilly's retatrutide shows promising
Description
doi: 10.1126/science.abf8683 99 KizilkayaHSSrensenKVKibsgaardCJGasbjergLSHauserASSparre-UlrichAHet al
Patience during escalation is critical
Advertisement There are many known acute pancreatitis risk factors
Send Press Release
But theres a catch
